Chronic lymphocytic leukemia (CLL) is a mature B-cell lymphoid neoplasm characterized by the presence of a clonal population of CD5+, CD19+ and CD23+ B-cell lymphocytes accumulating in the peripheral blood, bone marrow, lymph nodes and/or spleen [1]. The gene discussed is FCER2; the disease is B-cell chronic lymphocytic leukemia.